FDA
-
-
-
-
-
-
-
Celularity Receives Preliminary Assessment of Product Classification and Jurisdiction for Its Investigational Celularity Tendon Wrap (CTW) to be Regulated as a Device Within U.S. Food and Drug Admini
-
-
-
-
-
-
-
Celularity (CELU) Publishes New Data Demonstrating Placental-derived Natural Killer Cells
-
-
-
-
-
-
-
Celularity Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Juncti
-
-
-
-
-
-
-
Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric and Gastroesophageal Junction
-
-
-
240,055 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All